Exploring how forgiveness affects quality of life in people living with HIV
Influence of Resentment and Forgivingness on Quality of Life in People Living With HIV
This study looks at how forgiveness might improve the quality of life for people living with HIV by reducing stress and resentment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 206 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Trial ID | NCT05660148 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the relationship between forgiveness, resentment, and quality of life among individuals living with HIV. It aims to understand how a person's propensity to forgive can influence their mental and physical health, particularly in the context of stress and stigma associated with HIV. By examining these dynamics, the study seeks to highlight forgiveness as a potential coping mechanism that may improve health outcomes for this population. Participants will be followed at the Amiens University Hospital, with a focus on their experiences and perceptions related to forgiveness and stress.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals living with HIV who are stable in their treatment and can participate in follow-up consultations.
Not a fit: Patients who are moribund, illiterate, or do not speak French may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how fostering forgiveness may enhance the quality of life for individuals living with HIV.
How similar studies have performed: Previous studies have indicated that forgiveness can positively impact mental and physical health, suggesting that this approach may yield beneficial results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Belonging to the PLHIV followed at the Amiens University Hospital, not likely to move within the year * Possibility of follow-up in teleconsultation (usual support of the service) * Benefiting from a social security scheme * Consent to participate in the research Exclusion Criteria: * Erratic follow-up (non-compliance, predictable move) or moribund patient * Illiterate or not speaking french
Where this trial is running
Amiens
- CHU Amiens — Amiens, France (Recruiting)
Study contacts
- Study coordinator: Jean-Philippe Lanoix, Pr
- Email: lanoix.jean-philippe@chu-amiens.fr
- Phone: 03 22 08 80 51
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.